This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Radiotherapy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A majority of malignant melanomas are resistant to radiotherapy but good results have been reported from the primary treatment of lentigo maligna melanoma and ocular melanoma (1).

The use of radiotherapy is therefore on a symptomatic basis.

  • treatment of painful metastatic bone disease and brain secondaries
  • sometimes used to palliate disease at many sites, particularly cutaneous metastatic deposits
  • response rate is 40% at best

Reference:

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page